Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost versus placebo in Raynaud syndrome with or without systemic sclerosis
2006-000905-41Phase 4Completed
- Sponsor
- ao. Univ. Prof. Dr. Elisabeth Aberer
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Raynaud disease and systemic sclerosis (SSc) comparing Iloprost (Ilomedin) with Placebo (2 arms). Primary endpoints: Number of Raynaud attacks, Duration of Raynaud attacks and 1 more. Started May 2006; status: completed.
02
Drugs
iloprost
03
Conditions
Raynaud diseasesystemic sclerosis (SSc)
Beyond the preview
Go deeper on 2006-000905-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000905-41.